医务人员危害药品的职业暴露与防护研究进展

摘要/Abstract

摘要： 医疗机构部分医务人员在工作过程中常与危害药品接触,由此引发的职业暴露问题备受关注。危害药品对医务人员的健康影响包括但不限于恶性肿瘤风险增加和不良生殖结局等。因此,本文综述了医务人员危害药品的职业暴露及防护的研究进展,主要包括职业暴露途径、职业暴露风险监测、危害药品对健康的影响、职业安全防护措施、安全处理危害药品的障碍和危害药品职业暴露安全管理政策,以期为今后危害药品防护研究的发展提供参考。

关键词: 危害药品, 抗肿瘤药物, 职业暴露, 职业防护

Abstract: Occupational exposure to hazardous drugs among certain medical personnel during their work processes has drawn considerable attention due to resulting health risks. The impact of hazardous drugs on the health of healthcare workers includes but are not limited to increased cancer risk and adverse reproductive outcomes. Therefore,this paper summarizes the research progress on occupational exposure and protection of hazardous drugs for medical personnel,mainly including occupational exposure pathways,monitoring of occupational exposure risks,the impact of hazardous drugs on health,occupational safety protection measures,barriers in the safe handling of hazardous drugs,and policies for the occupational exposure safety management of hazardous drugs,in order to provide reference for the future development of hazardous drug protection research.

Key words: Hazardous drugs, Antineoplastic drugs, Occupational exposure, Occupational protection

中图分类号:

R181.3⁺1

李长琨, 王思璐, 董卫华. 医务人员危害药品的职业暴露与防护研究进展. [J]职业与健康, 2024, 40(22): 3145-3150.

LI Changkun, WANG Silu, DONG Weihua. Research progress on occupational exposure and protection of hazardous drugs among medical personnel. [J]OCCUPATION AND HEALTH, 2024, 40(22): 3145-3150.

参考文献

[1] CONNOR T H,MACKENZIE B A,DEBORD D G,et al.NIOSH List of Antineoplastic and Other Hazardous DrugsinHealthcareSettings[EB/OL].(2016-09)[2023-08-01].https://www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf.
[2] 中华人民共和国卫生部.静脉用药集中调配质量管理规范[EB/OL].(2010-04-23)[2023-08-01].http://www.nhc.gov.cn/bgt/s10787/201004/09f4230d6bce4f53a857979112850482.shtml.
[3] 赵美荣,王玉红.我国城市癌症早诊早治项目研究现状[J].护理研究,2023,37(10):1765-1771.
[4] 中华人民共和国职业健康司.国家职业病防治规划(2021—2025年)解读[EB/OL].(2021-12-17)[2023-08-01].http://www.nhc.gov.cn/zyjks/s7786/202112/0aab1083f4e94d199312f22ffc2a6ce6.shtml
[5] CHUN-YIP H,KAY T,DEMERS P A,et al.Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system[J].Ann Occup Hyg,2014,58(6):761-770.
[6] CONNOR T H,DEBORD D G,PRETTY J R,et al.Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers[J].J Occup Environ Med,2010,52(10):1019-1027.
[7] ZHANG J,BAO J,WANG R, et al.A multicenter study of biological effects assessment of pharmacy workers occupationally exposed to antineoplastic drugs in Pharmacy Intravenous Admixture Services[J].J Hazard Mater,2016,315:86-92.
[8] 尹红梅. 某医院静脉用药调配中心工作人员抗肿瘤药物职业暴露评估研究[J].中国当代医药,2020,27(18):179-182.
[9] CASTIGLIA L,MIRAGLIA N,PIERI M,et al.Evaluation of occupational exposure to antiblastic drugs in an italian hospital oncological department[J].J Occup Health,2008,50(1):48-56.
[10] SESSINK P J,LECLERCQ G M,WOUTERS D M,et al.Environmental contamination,product contamination and workers exposure using a robotic system for antineoplastic drug preparation[J].J Oncol Pharm Pract,2015,21(2):118-127.
[11] SESSINK P J M,TRAHAN J,COYNE J W,et al.Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device[J].Hosp Pharm,2013,48(3):204-212.
[12] NDAW S,DENIS F,MARSAN P,et al.Biological monitoring of occupational exposure to 5-fluorouracil:Urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel[J].J Chromatogr B,2010,878(27):2630-2634.
[13] ELSHAER N.Adverse health effects among nurses and clinical pharmacists handling antineoplastic drugs:Adherence to exposure control methods[J].J Egypt Public Health Assoc,2017,92(3):144-155.
[14] 梅小红,陈昌蕊,黄超,等.抗肿瘤药物对我国医务人员健康的影响及其防护研究进展[J].护理研究,2021,35(10):1766-1770.
[15] 李玉玲. 化疗药物对肿瘤科护士的职业危害与防护[J].解放军护理杂志,2013,30(14):52-54.
[16] 黄晓林. 化疗药物对肿瘤科护士的职业危害及防护措施[J].全科护理,2015,13(12):1121-1123.
[17] MCDIARMID M A,OLIVER M S,ROTH T S,et al.Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs[J].J Occup Environ Med,2010,52(10):1028-1034.
[18] HAGMAR L,BRGGER A,HANSTEEN I L,et al.Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes:Nordic study group on the health risk of chromosome damage[J].Cancer Res,1994,54(11):2919-2922.
[19] RATNER P A,SPINELLI J J,BEKING K,et al.Cancer incidence and adverse pregnancy outcome in registered nurses potentially exposed to antineoplastic drugs[J].BMC Nurs,2010,9(1):15.
[20] SELEVAN S G,LINDBOHM M L,HORNUNG R W,et al.A Study of occupational exposure to antineoplastic drugs and fetal loss in nurses[J].N Engl J Med,1985,313(19):1173-1178.
[21] SAUREL-CUBIZOLLES M J,JOB-SPIR A.Ectopic pregnancy and occupational exposure to antineoplastic drugs[J].Lancet,1993,341(8854):1169-1171.
[22] LAWSON C C,ROCHELEAU C M,WHELAN E A,et al.Occupational exposures among nurses and risk of spontaneous abortion[J].Am J Obstet Gynecol,2012,206(4):327.
[23] ZHANG X,ZHENG Q,LV Y,et al.Evaluation of adverse health risks associated with antineoplastic drug exposure in nurses at two Chinese hospitals:The effects of implementing a pharmacy intravenous admixture service[J].Am J Ind Med,2016,59(4):264-273.
[24] 刘雅玲,梁婉.化疗药物对肿瘤科护士的职业危害与防护[J].河南外科学杂志,2014,20(3):140-142.
[25] SPIVEY S,CONNOR T H.Determining sources of workplace contamination with antineoplastic drugs and comparing conventional iv drug preparation with a closed system[J].Hosp Pharm,2003,38(2):135-139.
[26] BUNING A W,GEERSING T H,CRUL M.The assessment of environmental and external cross-contamination in preparing ready-to-administer cytotoxic drugs:a comparison between a robotic system and conventional manual production[J].Int J Pharm Pract,2020,28(1):66-74.
[27] National Institute for Occupational Safety and Health.NIOSH alert; preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings[EB/OL].(2004-09-01)[2023-08-01].https://www.cdc.gov/niosh/docs/2004-165/pdfs/2004-165.pdf.
[28] 国家卫生健康委.关于印发静脉用药调配中心建设与管理指南(试行)的通知[EB/OL].(2021-12-20)[2023-08-01].http://www.nhc.gov.cn/yzygj/s7659/202112/6fc8ae699c1f4fefb9e80a80d4f4fa55.shtml.
[29] YODAIKEN R E,DIANNE B.OSHA work-practice guidelines for personnel dealing with cytotoxic(antineoplastic) drugs.Occupational Safety and Health Administration[J].Am J Hosp Pharm,1986,43(5):1193-1204.
[30] WALTON A M,EISENBERG S,FRIESE C.Hazardous drugs:Legislative and regulatory efforts to improve safe handling[J].Clin J Oncol Nurs,2017,21(2):254-256.
[31] Health and Safety Executive.Control of substances hazardous to health (Sixth edition)-The Control of Substances Hazardous to Health Regulations2002(as amended)[EB/OL].(2013-01-01)[2023-08-01].https://www.hse.gov.uk/pubns/priced/l5.pdf.
[32] PAŁASZEWSKA-TKACZ A,CZERCZAK S,KONIECZKO K,et al.Cytostatics as hazardous chemicals in healthcare workers' environment[J].Int J Occup Med Environ Health,2019,32(2):141-159.
[33] CONNOR T,MCLAUCHLAN R,VANDENBROUCKE J.Preface[J].Oncol Pharm Practice,2007,13(3_suppl):1-2.
[34] CYTOPREVENT.Directive2004/37/EC-carcinogens,mutagens or reprotoxic substances at work[EB/OL].(2021-01-25)[2023-08-01].https://cytoprevent.eu/2021/01/25/eu-policy-recommendations-preventing-occupational-exposure-to-cytotoxic-and-other-hazardous-drugs/.
[35] 中华人民共和国国家卫生和计划生育委员会.中华人民共和国国家卫生健康委员会[EB/OL].(2013-11-14)[2023-08-01].http://www.nhc.gov.cn/wjw/pjl/201412/806fe9a7171e4cf584c0d40ed093dfa7.shtml
[36] POLOVICH M,MARTIN S.Nurses'use of hazardous drug-handling precautions and awareness of national safety guidelines[J].Oncol Nurs Forum,2011,38(6):718-726.
[37] 张新琴,颜海燕.行为运作管理在妇科肿瘤护士化疗药物职业防护管理中的应用[J].中医药管理杂志,2022,30(2):194-195.
[38] BOIANO J M,STEEGE A L,SWEENEY M H.Adherence to precautionary guidelines for compounding antineoplastic drugs:A survey of nurses and pharmacy practitioners[J].J Occup Environ Hyg,2015,12(9):588-602.
[39] DEJOY D M,SMITH T D,WOLDU H,et al.Effects of organizational safety practices and perceived safety climate on ppe usage,engineering controls,and adverse events involving liquid antineoplastic drugs among nurses[J].J Occup Environ Hyg,2017,14(7):485-493.
[40] TOPÇU S,BEŞER A.Oncology nurses' perspectives on safe handling precautions:a qualitative study[J].Contemp Nurse,2017,53(3):271-283.
[41] EISENBERG S.Safe Handling and Administration of Antineoplastic Chemotherapy[J].J Infus Nurs,2009,32(1):23-32.
[42] FAZEL S S,KEEFE A,SHAREEF A,et al.Barriers and facilitators for the safe handling of antineoplastic drugs[J].J Oncol Pharm Pract,2022,28(8):1709-1721.
[43] EISENBERG S.NIOSH Safe Handling of hazardous drugs guidelines becomes state law[J].J Infus Nurs,2015,38(6):S25-S28.
[44] CHAN H K,LIM Y M.Cost analysis of Using a Closed-System Transfer Device(CSTD) for antineoplastic drug preparation in a Malaysian government-funded hospital[J].Asian Pac J Cancer Prev,2016,17(11):4951-4957.
[45] MARTIN S,LARSON E.Chemotherapy-Handling Practices of Outpatient and Office-Based Oncology Nurses[J].Oncol Nurs Forum,2003, 30(4):575-581.